Twist Bioscience's SynBio and NGS segments continue to generate strong growth despite macro challenges. Learn more about TWST stock here.

With a number of Irish agencies through to the Best of Europe Effie Awards- which will be announced on December 11 – Jay Reid ...

China: Enhertu, a blockbuster breast cancer drug of AstraZeneca, will be included in China's state-run health insurance ...

Researchers discovered that tumors grow uniformly throughout their mass, challenging the idea of faster growth at edges.

AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...

With growth slowing in urban and growth recovery plateauing in rural, Colgate is looking at a balanced mix of volume and price growth. Colgate Palmolive's top brass also suggested that the firm will ...

Formycon reports nine-month results for 2024 and continues growth trajectory with further operational success Excellent third quarter with product approvals for FYB202 in the key markets USA and ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

The Units will be sold on a non-brokered “private placement” basis in accordance with applicable Canadian securities laws and under applicable exemptions from prospectus and registration requirements ...

According to its latest financial report, in the first three quarters, Beijing-based Wantai Biopharm, a major HPV vaccine ...

Your future is waiting! ⏳ Here are your free predictions for the month of November This month, focus on your home and family ...

The Conference Forum, a life science industry research firm that develops annual conferences primarily around how to get therapeutics to patients faster, has announced record growth in attendees and ...